Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Galderma R&D
Age
22–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Subjects willing to comply with the requirements of the study and providing a signed written informed consent.
Non-pregnant, non-breastfeeding females, over the age of 21.
Subjects seeking treatment for the décolletage.
Subject was willing to comply with the requirements of the study and provide a signed written informed consent.
Subject had received treatment with GAL1906 in the main protocol.
You may not be if
Known/previous allergy or hypersensitivity to any injectable HA gel or to gram positive bacterial proteins.
History of allergy or hypersensitivity to lidocaine or other amidetype anesthetics, or topical anesthetics or nerve blocking agents (if such products are intended to be used for that subject).
Subject was pregnant or nursing AND has no mammogram taken post GAL1906 treatment.
Clareo Health | Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906
